The former is susceptible to P. vivax infection due to Duffy-positive phenotype, but most of them can be treated safely with primaquine; the latter is “resistant” to P. vivax malaria but, in case of infection, requires screening for G6PD activity before primaquine therapy. The gene discussed is G6PD; the disease is infection.